Navigation Links
SYNARC Appoints Ciaran Cooper as Vice President, Business Development
Date:2/9/2011

SAN FRANCISCO, Feb. 9, 2011 /PRNewswire/ -- SYNARC, the world's leading provider of medical image analysis services to the pharmaceutical and biotechnology industries, announced today that Ciaran Cooper has joined SYNARC to lead the sales and marketing efforts in support of the company's rapidly growing business in imaging services for clinical trials.

Ciaran Cooper, a pioneer in the clinical trials imaging services industry, brings over 20 years experience in medical imaging with an emphasis in business development, strategic planning, and management. He co-founded MIICRO, Inc. in 1994, the first imaging CRO specialized in early phase translational imaging with FDG PET. Since then, Cooper has worked for several imaging core labs as a senior manager in business development and thus brings with him a vast knowledge of various business models, therapeutic areas, and growth strategies.

"I'm thrilled to be joining SYNARC at this exciting time in their development," said Cooper. "SYNARC has always maintained a reputation for science-led, high quality service across a range of therapeutic areas and indications. In the last several years, they have successfully expanded their focus to include oncology and cardiology on top of their historic dominance in musculoskeletal and neurology – few people know how much oncology and cardiology work SYNARC is already engaged in; that's an exciting message to carry out to our customers. To be surrounded by so many bright minds all focused on delivering the highest level of quality to our customers is a dream come true. I'm really proud to be a part of this team."

Aaron Timm, Head of Imaging for CCBR-SYNARC, stated, "Ciaran offers us a very unique perspective on the industry. He has a vast knowledge of the imaging service arena and his reputation for hard work, creativity, and integrity fit well with our team. We're very happy to welcome him aboard."

About CCBR-SYNARC

CCBR-SYNARC's medical image analysis, biochemical marker, and clinical research center services enable life-science industry clients to execute clinical trials accurately while decreasing the time, uncertainty, and cost of product development. CCBR-SYNARC has partnered with industry leaders to bring numerous leading compounds to market across a broad spectrum of therapeutic areas. Our services integrate critical aspects of clinical-trial design and execution, from protocol design and subject recruitment to regulatory liaison on behalf of our clients.  Our expert radiologists and scientists are innovators in all aspects of medical image analysis and biochemical markers in drug development, and have pioneered many methods used in today's clinical trials.Media Contact:Joy Valderrama 415 817-8919 joy.valderrama@synarc.com(Logo: http://photos.prnewswire.com/prnh/20110113/SF29497LOGO)


'/>"/>
SOURCE SYNARC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CCBR-SYNARC Expands Electronic Data Capture Capabilities
2. Quark Pharmaceuticals Appoints New Chief Medical Officer
3. West Pharmaceutical Services, Inc. Appoints New Director
4. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
5. Curemark Appoints Preeminent Pediatrics Gastroenterologist
6. CVBT Appoints Dr. Nabil Dib as Principal Investigator for Phase II Heart Trial
7. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
8. Cytopia Appoints Study Chairman for JAK2 Clinical Trial
9. Enobia Pharma Appoints Industry Veterans with Commercial and Manufacturing Expertise to Expand Senior Management Team
10. NovaRx Appoints Industry Veteran as President and COO
11. Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... Denmark , Oct. 2, 2017 The Rebound ... in the struggle to reverse the tide of prescription drug ... for regulating their medicine intake and stepping down their dosage ... set to launch in December 2017; the first 100,000 people ... Learn more at http://www.rebound-solution.com/ ...
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation ... and home sensors for real-time monitoring of patients with ... nonprofit organization focused on disruptive health solutions for rare ... system to record and integrate behavioral, cognitive, physiological and ... ...
(Date:9/27/2017)... Israel and NEW YORK , Sept. 27, ... with mobile health and big data solutions, today announced that its MyDario ... Please check your local TV listings for when The Dr. Oz Show ... ... season this month. ...
Breaking Medicine Technology:
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
(Date:10/12/2017)... , ... October 12, 2017 , ... HMP , ... recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ ... on October 11, 2017. , The annual award competition recognizes editorial and design excellence ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the Health & Wellness ... Moonlight to raise money for the American Heart Association Heart Walk. Teams of up ... work together to keep their treadmills moving for 5 hours. Treadmills will start at ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health ... interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), an ... education, today announce a new strategic alliance. , As CPEN’s strategic partner, ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... wound care advancements to physician colleagues, skilled nursing facility medical directors and other ... Treacherous Waters of Wound Care." , "At many of these conferences we get ...
Breaking Medicine News(10 mins):